#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13554	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2465	676.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1619	1619	C	874	C,A	873,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13554	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2465	676.6	0	HET	.	.	.	C611T,A	.	611	611	C	1046	1046	C	849	C,T,A	657,191,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22638	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3950	713.5	0	.	n	.	0	T695C	SNP	695	695	T	1263	1263	C	841	C,T	840,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22638	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3950	713.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1905	1905	A	952	A	952	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22638	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3950	713.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2539	2539	C	794	C,T	793,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22638	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3950	713.5	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3165	3165	T	750	T,G,A	745,4,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22638	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3950	713.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2613	2613	A	722	A,C	720,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2134	folP	852	852	100.0	folP.l15.c4.ctg.1	1983	134.2	1	SNP	p	R228S	1	.	.	682	684	AGC	1206	1208	AGC	214;213;212	A;G;C	214;213;212	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5324	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3846	172.4	1	SNP	p	S91F	0	.	.	271	273	TCC	784	786	TCC	192;191;191	T;C,A;C	192;189,2;191	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5324	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3846	172.4	1	SNP	p	D95N	0	.	.	283	285	GAC	796	798	GAC	189;192;191	G,T;A;C,T	188,1;192;190,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5324	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3846	172.4	1	SNP	p	D95G	0	.	.	283	285	GAC	796	798	GAC	189;192;191	G,T;A;C,T	188,1;192;190,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1916	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1726	138.2	1	SNP	p	G45D	1	.	.	133	135	GAC	720	722	GAC	243;240;240	G,T;A;C	242,1;240;240	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1052	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1462	89.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3415	175.2	1	SNP	p	D86N	0	.	.	256	258	GAC	818	820	GAC	222;224;223	G;A,G;C	222;223,1;223	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3415	175.2	1	SNP	p	S87W	0	.	.	259	261	AGT	821	823	AGT	222;224;224	A,C;G;T,C	221,1;224;223,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3415	175.2	1	SNP	p	S87R	0	.	.	259	261	AGT	821	823	AGT	222;224;224	A,C;G;T,C	221,1;224;223,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3415	175.2	1	SNP	p	S87I	0	.	.	259	261	AGT	821	823	AGT	222;224;224	A,C;G;T,C	221,1;224;223,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3415	175.2	1	SNP	p	S88P	0	.	.	262	264	TCC	824	826	TCC	227;226;223	T;C;C	227;226;223	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4046	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3008	167.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1755	1757	GGC	216;216;216	G;G;C	216;216;216	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2882	156.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1487	1489	GCA	210;211;210	G;C,G;A,C	210;210,1;209,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2882	156.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1490	1492	ATC	205;204;203	A;T,A;C,A	205;203,1;202,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2882	156.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1502	1504	GTG	212;211;212	G;T,G;G,T	212;210,1;211,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2882	156.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1502	1504	GTG	212;211;212	G;T,G;G,T	212;210,1;211,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2882	156.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2006	2008	ACC	201;201;202	A,T,C;C;C,G	199,1,1;201;201,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2882	156.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2060	2062	GCG	168;169;167	G;C,T,G;G	168;165,2,2;167	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2882	156.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2060	2062	GCG	168;169;167	G;C,T,G;G	168;165,2,2;167	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2882	156.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2183	2185	GGC	198;200;203	G;G;C	198;200;203	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2882	156.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2192	2194	GGC	210;207;207	G;G;C	210;207;207	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2882	156.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2210	2212	CCG	209;210;206	C,G;C,T;G,T	207,2;209,1;205,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5062	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3654	173.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2506	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2366	132.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	885	885	C	201	C	201	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2400	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1726	172.7	0	.	p	.	0	I45V	NONSYN	133	135	ATT	557	559	GTT	199;198;197	G;T;T	199;198;197	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2400	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1726	172.7	0	.	p	.	0	N121S	NONSYN	361	363	AAC	785	787	AGC	170;171;173	A,C;G;C	169,1;171;173	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2400	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1726	172.7	0	.	p	.	0	N122K	NONSYN	364	366	AAC	788	790	AAA	174;172;173	A,C;A;A	173,1;172;173	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2400	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1726	172.7	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	851	853	GAA	188;187;187	G;A,C;A,T,C	188;185,2;184,2,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2400	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1726	172.7	0	.	p	.	0	V151A	NONSYN	451	453	GTA	875	877	GCA	191;190;190	G,C;C;A	190,1;190;190	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2400	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1726	172.7	0	.	p	.	0	K207_M208insK	INS	619	619	A	1043	1043	A	232	A	232	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2400	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1726	172.7	0	.	p	.	0	A212S	NONSYN	634	636	GCA	1061	1063	TCA	235;236;241	T,G;C;A	234,1;236;241	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2400	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1726	172.7	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1178	1178	T	187	T	187	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	248	porB3	990	161	93.79	porB3.l15.c4.ctg.2	163	59.8	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	78;78;78	A;C,T;T	78;77,1;78	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	248	porB3	990	161	93.79	porB3.l15.c4.ctg.2	163	59.8	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	78;78;78	A;G;T	78;78;78	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	248	porB3	990	161	93.79	porB3.l15.c4.ctg.2	163	59.8	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	78;78;78	G;A;C	78;78;78	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	248	porB3	990	161	93.79	porB3.l15.c4.ctg.2	163	59.8	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	80	82	TAC	78;78;78	T;A;C	78;78;78	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8624	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5368	200.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2248	2250	AAT	205;205;205	A;A;T,G	205;205;204,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1346	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1541	108.9	1	SNP	p	V57M	1	.	.	169	171	ATG	768	770	ATG	223;223;224	A;T;G	223;223;224	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
